Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides
about
Chemosensitivity assay in mice prostate tumor: Preliminary report of flow cytometry, DNA fragmentation, ion ratiometric methods of anti-neoplastic drug monitoring2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (2'F-ANA) modified oligonucleotides (ON) effect highly efficient, and persistent, gene silencingCrystal structures of DNA:DNA and DNA:RNA duplexes containing 5-(N-aminohexyl)carbamoyl-modified uracils reveal the basis for properties as antigene and antisense moleculesThe experimental use of antisense oligonucleotides: a guide for the perplexedLocked nucleic acid modified DNA enzymes targeting early growth response-1 inhibit human vascular smooth muscle cell growth.Newly designed six-membered azasugar nucleotide-containing phosphorothioate oligonucleotides as potent human immunodeficiency virus type 1 inhibitors.Vehicles for oligonucleotide delivery to tumours.A pharmacologic target of G3139 in melanoma cells may be the mitochondrial VDAC.Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomasAntisense imaging of gene expression in the brain in vivoThe design and exogenous delivery of siRNA for post-transcriptional gene silencing.Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.DNAzymes and cardiovascular disease.Anti-insulin-like growth factor-IIP3 DNAzymes inhibit cell proliferation and induce caspase-dependent apoptosis in human hepatocarcinoma cell linesInhibition of EGF Uptake by Nephrotoxic Antisense Drugs In Vitro and Implications for Preclinical Safety Profiling.Binding features of BCL2-targeted oligodeoxynucleotides with K562 cells.Protein Kinase C-α is a Critical Protein for Antisense Oligonucleotide-mediated Silencing in Mammalian CellsDesign of antisense oligonucleotides stabilized by locked nucleic acids.Synthesis, thermal stability and resistance to enzymatic hydrolysis of the oligonucleotides containing 5-(N-aminohexyl)carbamoyl-2'-O-methyluridines.Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2'-O-methyl RNA, phosphorothioates and small interfering RNA.Kaposi's sarcoma-associated herpesvirus activation of vascular endothelial growth factor receptor 3 alters endothelial function and enhances infection.Sequence-dependent cytotoxicity of second-generation oligonucleotides.Antisense Oligodeoxynucleotide Technology: Potential Use for the Treatment of Malignant Brain Tumors.Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake.Electronic Structures of LNA Phosphorothioate Oligonucleotides.Oligonucleotides suppress PKB/Akt and act as superinductors of apoptosis in human keratinocytes.New role for tRNA and its fragment purified from human urinary bladder carcinoma conditioned medium: inhibition of endothelial cell growth.Direct inhibition of EGF receptor activation in vascular endothelial cells by gefitinib ('Iressa', ZD1839).Novel PDGFbetaR antisense encapsulated in polymeric nanospheres for the treatment of restenosis.Keeping the biotechnology of antisense in context.
P2860
Q24798547-16FBC759-F26F-4B06-9371-528CC37ED063Q25255757-EE92BD67-838D-48F6-BAE6-C820F1984A4EQ27643996-F5C4918D-FF9E-4EBC-B224-EB6E573DB512Q28349648-C40EDB98-B268-48A8-954E-CDC5413BA763Q33832774-4BC60E1C-3033-474E-B613-8771D7CE594BQ34076980-18AAF550-AFA4-4F98-8AB0-CEBB7C6D19F5Q34518719-54625574-2817-4D88-B781-390BBDD6F1CDQ34624645-6BB95B0B-AC93-4B29-AB61-D9E0306D8B6FQ35789079-9A50AFE5-B414-417E-8B1A-9B1D716AED24Q35853732-D5F5951B-CE2B-4A87-8BBA-1112353E7196Q35950928-5A104271-9392-4942-AB1C-2B053A0FE5A2Q36918516-4C73BAD3-F10D-4C10-BF4B-8C86C13D28B4Q37153589-29E8E585-2677-438C-A4D4-C4CE74C49002Q37222630-D6F15E07-D134-46E4-80C2-BFE82714CD4BQ37718074-0EE47B0A-7072-440E-9C9B-7B65FB3D973BQ38333934-C313C49E-CE19-4DCD-BF81-0B8A9E739499Q38787499-C23C3EFA-41C4-4775-B26E-D2A2BBB6A060Q39600730-895196BB-4FE6-42FE-9C15-3EC8618903FBQ39756314-00B41ECE-4CC4-4767-9EAC-3AFC56088E2CQ39777950-3036995E-182C-4EC0-A74B-3EBA078F3DCCQ40425763-2DF17CEC-0BA8-4BFD-BF9C-B6032D649F68Q40479775-99F8CD3C-D8DB-4B84-A6B7-896DB49EA6FCQ40770171-1FD50354-FE30-46D5-84AD-5360B0855FF1Q40939824-2C50397D-9199-4671-8135-919DFA228F6AQ41192925-6A1B09C8-4A00-4190-937C-03648A33C8F6Q42124172-91B1DF78-A968-4E64-9A42-2D38791A3184Q42808140-A8C1E124-0C10-44B6-90B6-7936D9ED093AQ44971697-D12ED05A-36D5-4314-AD8A-3C6A431BB089Q45105336-4BB513D2-1F32-454E-8698-B21ADCF5CE78Q54157081-A1C008E3-DA2E-40BC-8C8D-28CFA21B899C
P2860
Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Cell-surface perturbations of ...... othioate oligodeoxynucleotides
@ast
Cell-surface perturbations of ...... othioate oligodeoxynucleotides
@en
type
label
Cell-surface perturbations of ...... othioate oligodeoxynucleotides
@ast
Cell-surface perturbations of ...... othioate oligodeoxynucleotides
@en
prefLabel
Cell-surface perturbations of ...... othioate oligodeoxynucleotides
@ast
Cell-surface perturbations of ...... othioate oligodeoxynucleotides
@en
P2093
P2860
P356
P1476
Cell-surface perturbations of ...... othioate oligodeoxynucleotides
@en
P2093
N I Goldstein
P Rockwell
W J O'Connor
P2860
P304
P356
10.1073/PNAS.94.12.6523
P407
P577
1997-06-01T00:00:00Z